Catharine E. Johnson
Plus aucun poste en cours
Profil
Catharine E.
Johnson worked as Head of Business Development at Regeneron Pharmaceuticals, Inc. and as Vice President of Corporate Development at Momenta Pharmaceuticals, Inc. from 2005 to 2013.
She also worked as Senior Vice President of Business Development at aTyr Pharma, Inc., Principal at Atlas Venture Advisors, Inc., and Head of Business and Corporate Development at Sesen Bio, Inc. Johnson holds a doctorate degree from The Johns Hopkins University.
Anciens postes connus de Catharine E. Johnson
| Sociétés | Poste | Fin |
|---|---|---|
| CARISMA THERAPEUTICS, INC. | Corporate Officer/Principal | - |
| REGENERON PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
| MOMENTA PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
| ATYR PHARMA, INC. | Corporate Officer/Principal | - |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Analyste en capital-investissement | - |
Formation de Catharine E. Johnson
| The Johns Hopkins University | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ATYR PHARMA, INC. | Health Technology |
| REGENERON PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |
Sesen Bio, Inc.
 Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Sesen Bio, Inc. is a late-stage clinical company, which engages in the development of targeted fusion protein therapeutics. It offers Vicineum and Proxinium, which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells. The company was founded by Reza Dana, K. Christopher Garcia, Gregory L. Verdine, Casey T. Weaver, and K. Dane Wittrup on February 25, 2008 and is headquartered in Cambridge, MA. | Health Technology |
